Notice of Change to Key Dates for RFA-NS-24-009: Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed)
Notice Number:
NOT-NS-24-007

Key Dates

Release Date:

July 6, 2023

Related Announcements

  • June 27, 2023 - Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed). See NOFO RFA-NS-24-009

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to change the receipt date for RFA-NS-24-009 - Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed).
 

Current Reads:

Open Date (Earliest Submission Date)

August 06, 2023

Letter of Intent Due Date(s)

Not Applicable

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
September 06, 2023September 06, 2023Not ApplicableMarch 2024May 2024July 2024

All applications are due by 5:00 PM local time of applicant organization. 

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

September 07, 2023
 

Revised to Read:

Open Date (Earliest Submission Date)

October 15, 2023

Letter of Intent Due Date(s)

Not Applicable

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
November 15, 2023November 15, 2023Not ApplicableFebruary 2024May 2024July 2024

All applications are due by 5:00 PM local time of applicant organization. 

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

November 16, 2023
 

No other changes to this NOFO.

Inquiries

Please direct all inquiries to:

Timothy LaVaute, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1447
Email: lavautetm@ninds.nih.gov